"to be honest, that was what i had almost expected," she said.
.
.
-
.
- . .
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. http://lm360.us/Rathgeb-neighbour-of-Kiddy-from-Tonstad?Tippinssi=99
.